Pharmaceutical - Financial, Pricing

Filter

Current filters:

FinancialPricing

Popular Filters

1 to 25 of 39 results

New Zealand to fund Vidaza and Revlimid

New Zealand to fund Vidaza and Revlimid

13-08-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC says it has approved a proposal for funding…

Celgene Corp.FinancialHealthcareNew ZealandPharmaceuticalPricingRevlimidVidaza

PhRMA comments on Medicare Rights Center paper

25-07-2014

“Finding viable solutions to contain Medicare costs is critically important, but imposing price controls…

FinancialHealthcarePharmaceuticalPricingUSA

Further Indian drug price cuts, and price control categorization likely

30-06-2014

In order to make drugs more affordable to the country’s public, the Indian government is likely to…

FinancialIndiaPharmaceuticalPoliticsPricing

Indian govt to penalize drugmakers for overcharging

Indian govt to penalize drugmakers for overcharging

06-05-2014

In a major crackdown, India's drug price regulator, the National Pharmaceutical Pricing Authority (NPPA)…

CiplaFinancialGlaxoSmithKlineIndiaPharmaceuticalPricing

Pharma Summit: AIDS activists picket to demand South African reform

Pharma Summit: AIDS activists picket to demand South African reform

14-03-2014

Delegates at The Economist’s Pharma Summit in London yesterday were greeted by AIDS activists picketing…

Anti-viralsFinancialLegalPharmaceuticalPricingSouth AfricaUK

Spain continues reduction of pharma spending and starts adopting value based pricing

04-02-2014

The Spanish Ministry of Health last week announced pharmaceutical spending data, which showed a new drop…

EuropeFinancialGenericsHealthcarePharmaceuticalPricingSpain

Pharma multinationals facing more pricing problems in India

Pharma multinationals facing more pricing problems in India

03-02-2014

Even as a battle royal appears to be brewing between India's drug price regulator, the National Pharma…

Asia-PacificAstraZenecaFinancialGlaxoSmithKlineIndiaNovartisPfizerPharmaceuticalPricing

Lack understanding of the impact of global drug pricing on profits, finds Model N survey

10-12-2013

More than half (58%) of pharmaceutical companies believe the challenges of global drug pricing are not…

FinancialGlobalPharmaceuticalPricing

BIA warns that UK government pricing proposals would damage UK biotech

20-08-2013

The BioIndustry Association (BIA), the UK trade association for the innovative biotechnology sector,…

AvastinBayerEuropeEyleaFinancialLucentisPharmaceuticalPoliticsPricingRegeneronRoche

Australia's price disclosure change to put even more pressure on pharmacies, says Pharmacy Guild

05-08-2013

The Australian government last week announced plans that would save patient hundreds of dollars a year…

Asia-PacificFinancialPharmaceuticalPricing

EU Commission investigates alleged aid to German Pharma

29-07-2013

The European Commission revealed last week that it has opened an in-depth investigation to verify whether…

BiotechnologyEuropeFinancialPharmaceuticalPricing

EU Pharma leaders call for right balance between health care budget and economic growth objectives

10-06-2013

The Executive Committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA),…

EuropeFinancialPharmaceuticalPoliticsPricingRegulation

Generic medicines pricing reforms deliver significant savings to Australian government, says CSES report

22-05-2013

Australia's 2010 Pharmaceutical Benefits Scheme (PBS) reforms have delivered the government significant…

Asia-PacificFinancialGenericsHealthcarePharmaceuticalPricing

R-Pharm to invest 100 million euros in building a Turkish production plant

22-05-2013

R-Pharm, one of Russia's leading pharmaceutical producers, has officially announced the initiation of…

EuropeFinancialPharmaceuticalPricingProductionR-Pharma

Access to medicines in Europe: the EU cannot save banks while sacrificing people's health

20-05-2013

In a seminar hosted last week by the Group of the Progressive Alliance of Socialists & Democrats (S&D)…

EuropeFinancialHealthcarePharmaceuticalPoliticsPricing

Australia's 2013-14 Budget includes investment in health services and PBS

14-05-2013

The Australian government today (May 14) presented its Budget for 2013-2014, saying that it delivers…

Asia-PacificFinancialGenericsPharmaceuticalPoliticsPricing

Briefs: Elan tender offer; German drug price review; Daiichi Sankyo pays milestone

19-04-2013

Ireland-based drugmaker Elan (NYSE: ELN) yesterday reported final results of its modified Dutch auction…

ActemraAmgenAnticalinBayerElanFinancialNovo NordiskPharmaceuticalPradaxaPricingProliaRegulationResearchRocheVictozaXarelto

Proposal to list AstraZeneca's Brilinta in New Zealand

26-03-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to fund the…

Asia-PacificAstraZenecaBrilintaCardio-vascularFinancialHealthcarePharmaceuticalPricingticagrelor

For first time in 20 years, Australia's PBS spending in decline

22-03-2013

For the first time in 20 years government expenditure on the Pharmaceutical Benefits Scheme (PBS) in…

Asia-PacificFinancialGenericsHealthcarePharmaceuticalPricing

The solution for Spanish pharma companies lies abroad

13-03-2013

The pressure on the prices of medicines by Spanish government has seen the pharmaceutical market in Spain…

AlmirallEuropeFinancialGrifolsPharmaceuticalPricingRegulationZeltia

Health care in Greece: an accident waiting to happen, says pharma trade group

11-03-2013

Due to repeated failures on the government's part, the health care sector in Greece has reached a definite…

EuropeFinancialHealthcarePharmaceuticalPricing

US health care law allows consumers to easily find and compare options, says HHS Secretary

21-02-2013

US Department of Health and Human Services (HHS) Secretary Kathleen Sebelius yesterday announced a final…

FinancialHealthcareNorth AmericaPharmaceuticalPricing

Australia to subsidize groundbreaking hepatitis C drugs under PBS

19-02-2013

The Australian government said on February 19 that it is extended subsidies of important medicines each…

Anti-viralsAsia-PacificFinancialHealthcareIncivoJohnson & JohnsonMerck & CoPharmaceuticalPricingVictrelis

1 to 25 of 39 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top